ONCOLOGY LETTERS 15 85458555 2018 Identification subtypespecific prognostic signatures Cox models redundant gene elimination SUYAN TIAN Division Clinical Research The First Hospital Jilin University Changchun Jilin 130021 PR China Received September 29 2017 Accepted March 2 2018 DOI 103892ol20188418 Abstract Lung cancer LC leading cause cancer associated mortalities worldwide Adenocarcinoma AC squamous cell carcinoma SCC account 70 cases LC Since AC SCC distinct diseases corresponding prognostic genes associated patient survival time expected different To date studies distinguished patients good prognosis poor prognosis specific subtype In present study Cox filter model feature selection algorithm identifies subtypespecific prognostic genes incorporate pathway information eliminate redundant genes adopted By applying proposed model data nonsmall cell lung cancer NSCLC demonstrated redundant gene elimination search space restriction improve predictive capacity model stability resulting prognostic gene signatures To conclude prefiltering procedure incorporates pathway informa tion screening likely irrelevant genes prior complex downstream analysis recommended Furthermore feature selection algorithm considers redundant gene elimination preferable consideration Introduction Lung cancer LC leading cause cancerassociated mortalities worldwide Histologically LC stratified categories small cell lung cancer SCLC nonsmall cell lung cancer NSCLC prevalent 1 NSCLC classified major subtypes adenocarcinoma AC squamous cell carcinoma SCC account 70 total cases LC 2 Since AC SCC differ cell origin location Correspondence Professor Suyan Tian Division Clinical Research The First Hospital Jilin University 71 Xinmin Street Changchun Jilin 130021 PR China Email windytianhotmailcom Key words pathway information Cox model nonsmall cell lung cancer feature selection survival prediction subtypespecific prognosis redundant gene elimination lung growth pattern molecular mechanisms regarded distinct diseases 3 Until recently NSCLC subtypes typically treated thera peutic approaches 1 Apart lack timely detection tumors administration homogenous treatments NSCLC patients regardless histology subtypes account substantial improvement 5year survival rate patients NSCLC years 34 Therefore personalized therapeutic strategies AC SCC patients highly desirable necessitates identification subtypespecific prognostic molecular markers AC SCC Feature selection variable selection aims selecting gene signature subset thousands genes objectives including diagnosis diseases segmentation disease subtypes drug response survival predic tion patients currently routine practice bioinformatics 56 Regarding NSCLC extensive efforts devoted distinguishing AC SCC distinguish patients good prognosis poor prognosis aid feature selection algorithms 3711 Compared diagnosis task classification task demonstrated prognosis task difficult accomplish 1213 Furthermore present study focused subtypespecific prognosis extra consider ation subtype information introduce complexity statistical modeling Subtypespecific prognostic genes identified separate application feature selection method subtype modification existing method enable identification subtypespecific prognostic genes 14 Compared separate modeling method feature selection algorithms handle survival data LASSO method random forest method implemented subtype natural extension theoretically sound accompanied extra statistical complexity 15 The feature selection algorithms Cox filter method CoxThreshold Gradient Descent Regularization CoxTGDR method 1516 belong natural extension category Both Cox filter method CoxTGDR method proposed authors These methods based seminal model survival analysis A Cox regression model 17 Gene expression profiles contain grouping structure genes inside group highly correlated fore likely cofunction affect biological 8546 TIAN PROGNOSTIC GENES FOR LUNG CANCER SUBTYPES processes 1819 However Cox filter method CoxTGDR method typical genebased feature selec tion methods underlying grouping structure ignored 20 By contrast pathwaybased feature selection method incorporates grouping structure explicitly implicitly guide selection relevant genes 21 Many studies demonstrated pathwaybased feature selec tion method usually superior genebased counterpart terms predictive capacity model stability biological interpretation 2125 Furthermore failure account correlations genes result redundant genes included increase false positive rate As Cox filter method screens relevant genes individually Materials Methods section details control false positive rate The simulations conducted previous studies 1516 justified point Until drawback false positive rate fully addressed widespread application Cox filter method remains challenging In article Cox filter method extended resulting extension accounts interac tionsdependency genes eliminates redundant genes The GeneRank method 26 employed prefilter genes subsequently average correlation coef ficients calculated determine correlation specific gene genes search space Given GeneRank method prefilter genes previous study present authors 14 studies similarities Nevertheless objectives studies differ dramatically The aim previous study 14 illustrate different outcomes segmentation different subtypes versus predicted survival time corresponding relevant genes differ supervised learning method preferred unsupervised method By contrast present study focuses identification subtypespecific gene signatures After proposed procedure applied NSCLC gene expression data compared relevant algorithms proposed procedure identify gene signatures better predictive performance meaningful biological implication methods determined Materials methods Experimental data The microarray data included GSE30219 GSE37745 GSE50081 datasets publicly assess able Gene Expression Omnibus GEO httpswww ncbinlmnihgovgeo repository The inclusion criteria Being profiled Affymetrix HGU133 Plus 20 plat form ii inclusion AC SCC subtypes iii inclusion early pathological stages stage I II iv administration adjuvant therapy patients v availability raw data preprocessing procedure obtain gene expression values There 85 AC 21 SCC patients 40 AC 24 SCC patients 127 AC 42 SCC patients GSE30219 GSE37745 GSE50081 respectively In total 339 patients integrated dataset combined datasets served training set present study The RNASeq data downloaded The Cancer Genome Atlas Data Portal level 3 httpstcgadatancinih govtcga The cohorts considered LUAD AC subtype LUSC SCC subtype By restricting patients early stages disease undergone adjuvant treatment survival information available 70 AC 55 SCC patients included Preprocessing procedures Raw data CEL files microarray data sets downloaded GEO reposi tory The expression values obtained fRMA algorithm 27 normalized quantile normal ization separately experiment Then expression values studies combined COMBAT algorithm 28 eliminate potential batch effects The resulting data served training set referred integrated dataset Countspermillion CPM values RNAseq data calculated log2 transformed Voom function 29 R limma package 30 The RNAseq data test set validate performance resulting prognostic signa tures There 14573 unique genes annotated microarray data RNAseq data The proteintoprotein interaction information retrieved Human Protein Reference Database HPRD httpwwwhprdorg There 9672 proteincoding genes annotated HPRD database Release 9 The downstream analysis carried overlapped 8023 genes annotated microarray data RNAseq data HPRD database Compared previous study authors training set total genes consideration different present study Specifically data GSE50081 experiment train prognostic signatures number prefiltering steps performed downsize number genes consideration microarray data 6202 16 Statistical methods Cox filter method The Cox filter method 16 identify genes informative survival rate ACSCC histology subtypes In method gene fit Cox model The hazard function patient gene g g1p given Eq 1 XijXij1XijpT represents actual expression values p genes consideration λ0gt unknown baseline hazard function I jSCC indicator takes value 1 histology subtype j patient SCC value 0 The values βACg β2g βSCCg β2gβ3g determine subtypespecific prognostic genes exist Specifically βACg0 βSCCg0 corresponds ACspecific gene βSCCg0 βACg0 corresponds SCCspecific gene GeneRank The GeneRank method 26 calculates ranks genes accounting gene expression values connectivity information Firstly according connection recorded genes HPRD database pxp adjacency matrix p number genes consideration ONCOLOGY LETTERS 15 85458555 2018 8547 ijth jith components 1 gene gene j connected 0 Then GeneRank method solves following equation Eq 2 W stands adjacency matrix genes D diagonal matrix diagonal components record number genes specific gene connected gene network graph The gene expression value represented exp In GeneRank method d tuning parameter balancing effect expression value gene level importance inside genetogene interac tion network The gene expression values determine ranks genes d equals 0 On hand GeneRanks depend completely connectivity level genes d1 The default value d 05 In present study ranks generated GeneRank method rearrange genes ascending order search domain restricted ranked genes resulting list With filter important genes pathway connectivity expression difference ruled Redundant gene elimination To eliminate redundant genes highly correlated true causal genes tend selected feature selection algorithm particularly filter method method proposed previously 31 adopted account correlation coefficients genes filtering process Specifically average correlation coefficient candidate gene g genes restricted search space calculated follows Eq 3 corgj represents absolute value Pearsons correlation coefficient PCC gene g gene j S total number genes search space Then gene regarded relevant fits conditions corre sponding adjusted Pvalues Cox filter model 005 The BH procedure adjust multiple comparison problem ii average absolute correlation coefficients search space 02 With second restriction restriction average PCC value gene control redundant genes provided Originally new statistic defined multiplied adjusted Pvalue corgs gene g determine significance level genes The newly defined statistic named RRP Pvalue redundant gene removal However realized RRP fatal drawbacks For instance PCCs gene genes search space close 0 RRP extremely small Pvalue Cox filter model specific gene 1 As result RRP statistic overruled Sign average A regression model nonidentifiable number covariates exceeds number samples To avoid risk profile patient summarized sign average 1332 expression values selected genes Specifically subtype genes inside selected gene subset ACspecific SCCspecific prognostic genes stratified hazardous group H preventive group P according signs estimated effects Cox filter method β2g AC β2gβ3g SCC In hazardous group genes increased expression associated higher hazard included Conversely genes increment expression associated lower hazard mortality preventive group Of note sets notations HAC β2g 0 PAC β2g 0 AC patients HSCC β2gβ3g 0 PSCC β2gβ3g 0 SCC patients present study Denoting number genes inside gene set GS GS sign average AC patient ii1 n1 SCC patient j j n11 n defined respectively Eq 4 Statistical metrics The metric evaluate performance resulting prognostic gene signature censoringadjusted Cstatistic 33 followup period 0 τ It defined Eq 5 gX risk score subject predictor vector X Although value 05 Cindex corresponds random guess model moderate value 0607 indicates satisfactory performance discussed previously 34 In order evaluate stability robustness resulting signatures Rand index calculated With k runs resulting gene lists training k different datasets algorithm Rand index defined Eq 6 represents size intersection gene lists represents size union gene subsets gsi gsj gsi gsj obtained ith jth runs respectively Given present study aims select subtypespecific prognostic genes AC SCC metrics calculated separately AC SCC The proposed procedure consisted steps Firstly 8023 genes ranked ascending order according GeneRanks Secondly specific k value k varies 200 7800 increment 200 8023 search space number genes consideration restricted k ordered gene list corresponding adjusted Pvalues β2 β2β3 coef ficients gene absolute average correlation coefficients genes search space consid ered select prognostic genes AC SCC 8548 TIAN PROGNOSTIC GENES FOR LUNG CANCER SUBTYPES Figure 1 Flowchart proposed Cox filter method redundant gene elimination The Cox filter RGE method divided steps Ascending ranking genes consideration according ranks given GeneRank method ii restricting search space k genes fitting Cox filter models k genes iii calculating corresponding Pvalues average absolute Pearsons correlation coefficients gene determining relevance level gene Pvalue001 corgs02 deemed indicate relevance Steps 2 3 repeated grid values k k200 400 7800 8023 AC adenocarcinoma HPRD Human Protein Reference Database PCC Pearsons correlation coefficient RGE redundant gene elimination SCC squamous cell carcinoma Finally sign averages AC SCCspecific genes performance statistics calculated Steps 2 3 repeated possible k values The optimal k value AC SCC subtypes largest Cstatistics smallest sizes resulting gene signatures training set Fig 1 illustrates proposed procedure referred Cox filter method redundant gene elimination RGE The proposed procedure imposed search space restriction subsequently removed redundant genes inside restricted search space One argue procedure reverse order removal redundant genes followed search space restriction lead similar results However conducting redundant gene elimination result remaining genes uncorrelated The connectivity weights genes approximately level rearrangement genes according GeneRanks meaningless This method consideration pathway information Alternatively strategy instead combination GeneRank method redundant gene elimination employed However ONCOLOGY LETTERS 15 85458555 2018 8549 investigated scope present study Biological relevance gene set enrichment analysis The GeneCards database wwwgenecardsorg search biological relevance selected genes String software wwwstringdborg obtain enriched pathwaysgene sets ACspecific SCCspecific prognostic signatures Statistical language packages R language version 32 wwwrprojectorg carry statistical analysis present study The R packages included survival survAUC gelnet pathClass limma annotation affy hgu133plus2db Results In present study integrated data microarray experiments train final models The perfor mance resulting prognostic signatures validated RNASeq dataset independent micro array datasets Firstly Schoenfeld residuals calculated test proportional hazards assumption Cox models The Pvalues tests ranged 0003 09999 P005 141 values P001 27 values These numbers 5 1 total number genes Therefore proportional hazard assumption valid present study The Cstatistics model sizes training set given Fig 2 Based statistics resulting signatures 1000 genes AC 4000 genes SCC chosen presented Table I In table performance statistics Cox filter method 15 search space restriction redundant gene elimination Cox filter method redundant gene elimination space restriction original Cox filter method corresponding Cox filter method redundant gene elimination space restriction relevant algorithms CoxTGDR method 16 LASSO 35 AC SCC respectively listed The important finding additional redundant gene elimination indicates significant gains terms perfor mance statistics better Cstatistics smaller sizes resulting signatures consistent findings investigators 3136 Of note usually common test set poorer performance compared training set following reasons The different characteristics patients training set test set orand ii potential overfitting Given moderate value 06 Cindex regarded satisfactory performance 33 predictive performances resulting prognostic signatures obtained proposed procedure acceptable Furthermore training set previously data GSE50081 moderate sample size To date perfect performance achieved test set specific training set 1416 To address additional microarray experiments included training set present study combination studies The resulting signatures trained integrated data outperform signatures GSE50081 Figure 2 Determination optimal cutoffs AC subtype SCC subtype search spaces training NSCLC microarray data A The Cstatistic scenarios k taking different values k200 400 7800 8023 B The sizes resulting prognostic signatures scenarios The Cstatistic final sizes determine optimal cutoffs restricted search space AC SCC respectively largest Cindex smallest final model size chosen AC adenocarcinoma NSCLC nonsmall cell lung cancer SCC squamous cell carcinoma Another finding suitable restriction search space resulting prognostic signatures tend better performance restriction shown Table I Fig 2 This supports use prefiltering process ranking genes GeneRank method expression levels importance level gene network following selecting genes resulting list prior downstream analysis A prefiltering process screen genes highly unlikely relevant genes reduces computing burden Compared relevant algorithms Cox filter method best performance The Cox filter method easier implement computationally efficient CoxTGDR method advantage prefiltering procedure regards reducing computing burden obvious However present authors exclude probability CoxTGDR method optimal specific data structures advantage essential applications The patients stratified groupspatients high risk mortality low risk mortalityby median values resulting sign average scores patients training set Then KaplanMeier curves constructed Fig 3 curves compared logrank tests In training set Pvalues 8550 TIAN PROGNOSTIC GENES FOR LUNG CANCER SUBTYPES Table I Performance statistics nonsmall cell lung cancer application different algorithms Variable G1G1000 RGE AC G1G4000 RGE SCC G1G1000 AC G1G4000 SCC Coxfilter RGE AC Coxfilter RGE SCC Coxfilter AC Coxfilter SCC CoxTGDR AC CoxTGDR SCC LASSO AC LASSO SCC Size 35 44 45 380 259 119 329 836 62 76 9 10 Rand index Cstatistics Test set Training set 2697 1684 2604 2691 1667 1544 2405 2785 778 577 1487 1239 0725 0833 0703 0702 0699 0824 0681 0714 0684 0721 0724 0814 0694 0817 0714 0771 0610 0805 0538 0778 0559 0567 0583 0706 G1Gk The search space k genes ordered GeneRank method The results trained integrated dataset verified TCGA RNAsequencing data AC Adenocarcinoma RGE redundant gene elimination SCC squamous cell carcinoma TGDR Threshold Gradient Descent Regularization Figure 3 KaplanMeier plots ACspecific prognostic signature SCCspecific prognostic signature Based risk scores sign averages ACspecific signature AC patients sign averages SCCspecific signature SCC patients patients divided categories lowrisk group highrisk group medians risk scores cutoffs The Pvalues logrank tests comparing survival curves lowrisk highrisk groups shown AC adenocarcinoma SCC squamous cell carcinoma corresponding logrank tests 359x1014 AC 937x108 SCC respectively However corresponding Pvalues 0075 0123 test set indicating statistically nonsignificant difference survival ONCOLOGY LETTERS 15 85458555 2018 8551 curves highrisk lowrisk groups Furthermore cutoffs mean quartiles results remained Given mortalities recorded RNAseq data mortalities identified lowrisk groups predictive performance evaluated basis logrank tests acceptable For 35gene ACspecific prognostic signature 44gene SCCspecific prognostic signature GeneCards database searched biological relevance selected genes According GeneCards database CYP1A2 EGAG9 BRDT DDC ADCYAP1R1 PIWIL4 CENT2 TACR1 ABCA2 NEFH directly associated LC EGAG9 CYP1A2 CRISP3 BRDT BRSK1 DDC TACR1 ABCA2 CTNNA3 CCNO TAC3 CA6 directly associated AC ACspecific signatures Among SCCspecific signatures CP19A1 CYP3A4 KLF2 ACLY MASP1 SOX18 SERPINE2 BHLHE41 PDYN FGF4 NUAK1 GCNT1 CCT4 EBNA1BP2 directly associated LC FGF4 CYP19A1 PTPN2 CYP3A4 SERPINE2 SOX18 MMP20 MASP1 KLF2 ERP44 NUAK1 RAET1E directly associated SCC All respective remaining genes category indirectly associated LC AC SCC Among indirectly related genes genes associated corresponding diseases association wellknown cancer gene TP53 Additionally overlap ACspecific SCCspecific prognostic signatures Likewise overlap ACspecific prognostic SCCspecific prognostic signatures LASSO method implemented separately subtype By contrast substantial overlaps 32106 3019 ACspecific prognostic signature SCCspecific prog nostic signature CoxTGDR method The resulting prognostic signatures proposed procedure CoxTGDR separate LASSO analysis listed Table II The overlapping signatures identified LASSO method CoxTGDR method proposed procedure AC SCC presented Fig 4 Given overlap ACspecific SCCspecific prognostic signatures signatures intersected pathway level examined Using String software enriched pathwaysgene sets ACspecific prognostic SCCspecific prognostic signatures searched separately Using default cutoff value 005 False Discovery Rate FDR 5 GO Biological Process BP terms 1 GO Molecular Function MF terms 4 GO Cellular Component CC terms 0 KEGG pathways significantly enriched ACspecific prognostic genes respectively These sets gene listed Table III By contrast 11 BP terms 0 MF terms 23 CC terms 2 KEGG pathways significantly enriched SCCspecific genes The enriched gene sets SCCspecific prognostic signature listed Table IV Furthermore overlap enriched gene sets AC SCC indicating pathways enriched subtypespecific genes differ With redundant gene elimination identified ACspecific SCCspecific signatures differ completely levels genes pathways By contrast redun dant gene elimination substantial overlaps identified signatures suggest redundant gene elimi nation beneficial identifying genes specific particular subtype Discussion In article Cox filter model extended solve additional issues One issue incorporate pathway information excluding genes importance genetogene interaction network The issue involved eliminating potential redundant genes adding extra restriction average absolute correlation coefficients gene genes search space Using NSCLC gene expression data demonstrated proposed method outperform original Coxfilter method CoxTGDR method Similar Cox filter method CoxTGDR method capable identifying subtypespecific prognostic genes pathway information consideration However superior original Coxfilter method terms redundant gene elimination considers additive effects genes proposed method presents certain advantages Apart different objectives substantial differences present study previous study authors 14 Firstly patients classified highrisk group lowrisk group according survival time previous study 14 Secondly separation AC SCC subtypes previous study 14 resulting signatures general subtypes instead specific subtype Thirdly Radical Coordinate Visualization plot 36 feature selection previous study 14 imposes restrictions maximal size resulting gene signature Finally GSE50081 training set previous study 14 accounted 40 size inte grated data In previous study concluded good separation risk groups obtained best Cindex test set studies 054 14 By contrast present study survival time data directly larger data set identify subtypespecific prognostic genes Cox filter method restriction maximal size signature With advantages Cstatistics improved dramatically present study Consistent studies 3137 demonstrated present study redundant gene elimination beneficial effects feature selection With redundant gene elimination comparing Cox filter method RGE original Cox filter method resulting signatures better predictive performance smaller model sizes subtypespecific genes Furthermore present study demonstrated use prefiltering process prior downstream analysis beneficial consistent previous findings authors 9 work 3839 Therefore highly recommended carry prefiltering process particu larly complicated timeconsuming statistical method selected downstream analysis Certainly method conducting prefiltering procedure importance In present study GeneRank method 8552 TIAN PROGNOSTIC GENES FOR LUNG CANCER SUBTYPES Table II Resulting prognostic gene signatures proposed procedure CoxTGDR method separate LASSO analysis subtype Cox filter RGE SCCspecific ACspecific 557 443 LASSO SCCspecific ACspecific 526 474 CoxTGDR Overlapped genesa ACspecific 302 283 SCCspecific 415 EBAG9 KRT15 TACR1 FCER1A C6orf203 WNT7A ENG LMTK2 NF2 ZPBP TENC1 RAD50 CRYAA MASP1 IL1A SATB1 CDH5 TMF1 AKT1 N4BP3 NLRP4 ADCYAP1R1 GRM6 ERMAP GRK7 TACR1 CTNNA3 PAH CCNO RAB3C CA6 SPINK5 PIWIL4 RABGAP1 SLC22A4 NEURL2 SNX24 BRDT NEFH PLCD4 ABCA2 DDC CRISP3 SIRPB1 CWC25 AAGAB SAP30L FBXO44 EBAG9 BRSK1 GABRB1 CYP1A2 CETN2 TAC3 PASK EIF1AY SLC22A9 ZNF518A CYP3A4 PLAC8 EBNA1BP2 NYNRIN BHLHE41 EVC2 NCOA7 NUAK1 CPN2 CYP19A1 BCAP29 KCNJ8 FAM115A CKAP2 KLF2 SOX18 ANKRD7 PKN2 FGF4 PTPN2 GCNT1 GABRA4 TAF1B CCT4 CCDC42 BFSP2 ZFAND5 SERPINE2 RBM11 PDYN PGS1 RAET1E RYR3 ZPBP SLC17A1 ACLY MMP20 NUDT5 ERP44 MASP1 COMMD6 DR1 MICALCL PRMT6 SEMA3A IBTK HUS1B DDB2 RNF32 PPCDC ZNF91 DRD4 IL5RA ASCL2 GABARAPL1 NRG1 GTF2A1L PRLHR DCP1B NUP205 PLEKHG4 EMB ADAM2 SSR4 FAM71C KRT2 SIM1 PAPPA2 EPB41L1 PAIP2B TM4SF1 KRT15 ELSPBP1 AKAP4 RHOD CD177 ALOX12B MMP3 ACTR1B ABCC2 TTPAL DNAJB2 SLC6A2 PKP1 GCNT1 STRA13 NUMA1 IL1F10 E2F2 SLC2A4 RNF220 AP4E1 LSM10 CPSF7 TRIM63 ALOX12 CEACAM3 CARD16 COL23A1 SARS2 PITX1 NGFR N4BP3 GNRHR PAH MBD6 VAV2 APIP RDX CLNK SLC1A6 STXBP6 HIST1H1C LMX1A GPR26 RAPSN PSMF1 EPHA4 UPK2 RGS13 NUP88 RRP1B FUBP3 NFIB KRT85 RAD52 PRKAG1 CD3EAP ARG1 KCNA10 FGF10 ZNF417 MAP4 ATG4B FANCC JDP2 EIF2B1 KLK6 LINGO1 RFXAP ZBTB25 IL5 S100A1 BIRC3 GRIN2B FBXW7 aGenes overlapped ACspecific prognostic signatures SCCspecific prognostic signatures The proportion stratum ACspecific genes SCCspecific genes overlapped genes listed category AC lung adenocarcinoma SCC lung squamous cell carcinoma RGE redundant gene elimination TGDR Threshold Gradient Descent Regularization ONCOLOGY LETTERS 15 85458555 2018 8553 Table III Enriched GO terms Kyoto Encyclopedia Genes Genomes pathways 35gene lung adenocarcinoma specific prognostic signature Pathway ID Cellular component GO0002199 GO0005832 GO0044297 GO0005874 Biological process GO0007339 GO1901998 GO0051084 GO0007338 GO0006457 Molecular function GO0051082 Pathway description Zona pellucida receptor complex Chaperonincontaining Tcomplex Cell body Microtubule Binding sperm zona pellucida Toxin transport De novo posttranslational protein folding Single fertilization Protein folding Unfolded protein binding FDR 484x1014 825x1012 366x104 504x103 139x108 150x106 332x106 664x106 519x104 237x103 The 35gene lung adenocarcinoma prognostic signature identified Cox filter method redundant gene elimination The search space restricted 1000 genes orders obtained GeneRanks method FDR False Discovery Rate GO Gene Ontology Figure 4 Venndiagrams respective ACspecific SCCspecific prognostic signatures selected proposed method CoxTGDR method LASSO method These Venndiagrams showed overlaps signatures selected different feature selection methods AC lung adenocarcinoma EBAG9 estrogen receptor binding site associated antigen 9 KRT15 keratin 15 MASP1 mannan binding lectin serine peptidase 1 RGE redundant gene elimination SCC lung squamous cell carcinoma TACR1 tachykinin receptor 1 TGDR Threshold Gradient Descent Regularization ZBP1 ZDNA binding protein 1 considers pathway information Numerous studies previously demonstrated incorporating pathway information improves predictive capacity feature selec tion method 2125 Likewise prefiltering procedure incorporates pathway information helpful feature selection process To conclude GeneRank method preferable prefiltering procedure method consider pathway information moderated ttests R limma package 30 Acknowledgements The author like thank Ms Bing Wang Jilin University preparing TIFF formatted figures Funding The present study supported Natural Science Foundation China grant 31401123 8554 TIAN PROGNOSTIC GENES FOR LUNG CANCER SUBTYPES Table IV Enriched GO terms KEGG pathways 44gene SCC subtype specific prognostic signature Pathway ID Cellular component GO0005681 GO0071013 GO0030529 GO0071942 GO0097525 GO0005686 GO0016607 GO0005654 GO0044428 GO0000974 GO0005684 GO0043227 GO0032991 GO0043226 GO0044424 GO0031981 GO0097458 GO0031410 GO0044446 GO0005622 GO0016023 GO0036477 GO0043231 Biological process GO0000398 GO0008380 GO0006397 GO0007217 GO0060359 GO0000715 GO0043279 GO0032355 GO0043278 GO0046878 GO0006289 KEGG pathways 3040 3420 Pathway description Spliceosomal complex Catalytic step 2 spliceosome Ribonucleoprotein complex XPC complex Spliceosomal snRNP complex U2 snRNP Nuclear speck Nucleoplasm Nuclear Prp19 complex U2type spliceosomal complex Membranebounded organelle Macromolecular complex Organelle Intracellular Nuclear lumen Neuron Cytoplasmic vesicle Intracellular organelle Intracellular Cytoplasmic membranebounded vesicle Somatodendritic compartment Intracellular membranebounded organelle mRNA splicing spliceosome RNA splicing mRNA processing Tachykinin receptor signaling pathway Response ammonium ion Nucleotideexcision repair DNA damage recognition Response alkaloid Response estradiol Response morphine Positive regulation saliva secretion Nucleotideexcision repair Spliceosome Nucleotide excision repair FDR 112x1013 534x1012 233x107 711x106 911x106 225x104 137x103 432x103 432x103 558x103 166x102 168x102 176x102 176x102 176x102 231x102 240x102 249x102 249x102 301x102 467x102 467x102 467x102 362x1011 274x1010 233x109 260x109 428x103 943x103 164x102 200x102 427x102 427x102 438x102 466x1019 349x102 The 44gene SCC prognostic signature identified Cox filter method redundant gene elimination The search space restricted 4000 genes The orders obtained GeneRanks method FDR False Discovery Rate GO Gene Ontology KEGG Kyoto Encyclopedia Genes Genomes SCC squamous cell carcinoma Availability data materials Cancer Genome Atlas Data Portal level 3 httpstcgadata ncinihgovtcga All data present study publicly assessable Specifically microarray data included GSE30219 GSE37745 GSE50081 datasets Gene Expression Omnibus GEO httpswwwncbinlmnihgovgeo reposi tory RNASeq data downloaded The Authors contributions ST conceived designed study analyzed data interpreted results wrote paper ONCOLOGY LETTERS 15 85458555 2018 8555 Ethics approval consent participate Not applicable Consent publication Not applicable Competing interests The authors declare competing interests References 1 LemjabbarAlaoui H Hassan OU Yang YW Buchanan P Lung cancer Biology treatment options Biochim Biophys Acta 1856 189210 2015 2 Lu C Onn A Vaporciyan A Cancer lung In HollandFrei Cancer Medicine Kufe DW Pollock RE Weichselbaum RR Bast RC Gansler TS Holland JF Frei E eds 8th edition Peoples Medical Publishing House Shelton CT 2010 3 Pikor LA Ramnarine VR Lam S Lam WL Genetic alterations defining NSCLC subtypes therapeutic implications Lung Cancer 82 179189 2013 4 Siegel R Naishadham D Jemal A Cancer statistics 2012 CA Cancer J Clin 62 1029 2012 5 Saeys Y Inza I Larrañaga P A review feature selection techniques bioinformatics Bioinformatics 23 25072517 2007 6 Hira ZM Gillies DF A review feature selection feature extraction methods applied microarray data Adv Bioinformatics 2015 198363 2015 7 BenHamo R Boue S Martin F Talikka M Efroni S Classification lung adenocarcinoma squamous cell carcinoma samples based gene expression profile sbv IMPROVER Diagnostic Signature Challenge Syst Biom 1 8392 2013 8 Tian S Suárezfariñas M HierarchicalTGDR Combining biological hierarchy regularization method multiclass classification lung cancer samples highthroughput geneexpression data Syst Biom 1 93102 2013 9 Tian S SuárezFariñas M MultiTGDR A regularization method multiclass classification microarray experiments PLoS One 8 e78302 2013 10 Zhu CQ Ding K Strumpf D Weir BA Meyerson M Pennell N Thomas RK Naoki K LaddAcosta C Liu N et al Prognostic predictive gene signature adjuvant chemotherapy resected nonsmallcell lung cancer J Clin Oncol 28 44174424 2010 11 Der SD Sykes J Pintilie M Zhu CQ Strumpf D Liu N Jurisica I Shepherd FA Tsao MS Validation histologyindependent prognostic gene signature earlystage nonsmallcell lung cancer including stage IA patients J Thorac Oncol 9 5964 2014 12 Zhao Q Shi X Xie Y Huang J Shia B Ma S Combining multidimensional genomic measurements predicting cancer prognosis Observations TCGA Brief Bioinform 16 291303 2014 13 Zhao SD Parmigiani G Huttenhower C Waldron L Másomenos A simple sign averaging method discrimination genomic data analysis Bioinformatics 30 30623069 2014 14 Tian S Classification survial prediction earlystage lung adenocarcinoma squamous cell carcinoma patients Oncol Lett 14 54645470 2017 15 Tian S Identification subtypespecific prognostic genes earlystage lung adenocarcinoma squamous cell carcinoma patients embedded feature selection algorithm PLoS One 10 e0134630 2015 16 Tian S Wang C An MW Test existence histology subtypespecific prognostic signatures early stage lung adenocarcinoma squamous cell carcinoma patients Coxmodel based filter Biol Direct 10 15 2015 17 Cox DR Regression models lifetables J R Stat Soc B 34 187220 1972 18 Wang S Nan B Zhou N Zhu J Hierarchically penalized Cox regression grouped variables Biometrika 96 307322 2009 19 Breheny P Hunag J Penalized methods bilevel variable selection Stat Interface 2 369380 2009 20 Tian S Wang C Chang HH Sun G Identification prog nostic genes gene sets earlystage nonsmall cell lung cancer bilevel selection methods Sci Rep 7 46164 2017 21 Tian S Chang HH Wang C WeightedSAMGSR Combining significance analysis microarraygene set reduction algorithm pathway topologybased weights select relevant genes Biol Direct 11 50 2016 22 Johannes M Brase JC Fröhlich H Gade S Gehrmann M Fälth M Sültmann H Beissbarth T Integration pathway knowledge reweighted recursive feature elimination approach risk stratification cancer patients Bioinformatics 26 21362144 2010 23 Chen L Xuan J Riggins RB Clarke R Wang Y Identifying cancer biomarkers networkconstrained support vector machines BMC Syst Biol 5 161 2011 24 Sun H Lin W Feng R Li H Network regularized highdimensional Cox regression analysis genomic data Stat Sin 24 14331459 2014 25 Sokolov A Carlin DE Paull EO Baertsch R Stuart JM Pathwaybased genomics prediction generalized elastic net PLoS Comput Biol 12 e1004790 2016 26 Morrison JL Breitling R Higham DJ Gilbert DR GeneRank Using search engine technology analysis microarray experiments BMC Bioinformatics 6 233 2005 27 McCall MN Bolstad BM Irizarry RA Frozen robust multi array analysis fRMA Biostatistics 11 242253 2010 28 Johnson WE Li C Rabinovic A Adjusting batch effects microarray expression data empirical bayes methods Biostatistics 8 118127 2007 29 Law CW Chen Y Shi W Smyth GK Voom Precision weights unlock linear model analysis tools RNAseq read counts Genome Biol 15 R29 2014 30 Smyth GK Limma Linear Models Microarray Data In Bioinformatics Computational Biology Solutions Using R Bioconductor 397420 2005 31 Gu J Lu Y Liu C Lu H Multiclass classification sarcomas pathway based feature selection method J Theor Biol 362 38 2014 32 Eng KH Wang S Bradley WH Rader JS Kendziorski C Pathwayindex models construction patientspecific risk profiles Stat Med 32 15241535 2013 33 Uno H Cai T Pencina MJ DAgostino RB Wei LJ On Cstatistics evaluating overall adequacy risk prediction procedures censored survival data Stat Med 30 11051117 2011 34 Laimighofer M Krumsiek J Buettner F Theis FJ Unbiased prediction feature selection highdimensional survival regression J Comput Biol 23 279290 2016 35 Tibshirani R Regression shrinkage selection Lasso J Royal Statistical Society Series B Methodological 58 267288 1996 36 Hoffman P Grinstein G Marx K Grosse I Stanley E DNA visual analytic data mining Proceedings Vis97 cat 97CB36155 1997 37 Ge R Zhou M Luo Y Meng Q Mai G Ma D Wang G Zhou F McTwo A twostep feature selection algorithm based maximal information coefficient BMC Bioinformatics 17 142 2016 38 Chu W Li R Reimherr M Feature screening fo timevarying coefficient models ultrahigh dimensional longitudinal data Ann Appl Stat 10 596617 2016 39 Yang G Yu Y Li R Buu A Feature screening ultrahigh dimensional Coxs model Stat Sin 26 881901 2016 This work licensed Creative Commons AttributionNonCommercialNoDerivatives 40 International CC BYNCND 40 License